FDA issues guidance on excipients for anti-counterfeiting; API-maker Rhodes accused of hazardous waste violations;

> The FDA has issued final guidance for the use of chemical identifiers for anti-counterfeiting. Guidance

> API-maker Rhodes Technologies, accused by the U.S. Environmental Protection Agency of violating hazardous waste laws, could be fined more than $250,000. Story

> NovaSterilis has been granted U.S. Patent 8,012,414 B2, "Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant." Release

> Chiesi Farmaceutici Spain will upgrade its CRM system to the Mobile Intelligence SaaS CRM Solution from Cegedim Relationship Management. Release

> Maria Crowe, senior VP for global drug product manufacturing, is being promoted to succeed retiring, 36-year vet Frank Deane as president of manufacturing operations at Eli Lilly ($LLY). Release

> The Indian Ministry of Health has approved a proposal to put 2D barcodes and scratch-off labels on medicines as a means of fighting counterfeiting. Story

> DASGIP, a supplier of parallel benchtop bioreactor systems, has unveiled the DASware bioprocessing solution for management of bioprocessing data. Release

> Cardinal Health has gained exclusive rights to distribute MicroPhage's KeyPath MRSA/MSSA blood testing kits in the U.S. and Canada in exchange for operational funding to develop products based on the same testing technology. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.